Yun-Jie Song

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Tian-Mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-Jie Tao, Xi-Yun Chen, Qin Han, Zhuo Cheng, Pei-Pei Shang, Yu-Long Dong, He-Ming Xu, Lie-Ping Guo, Dong-Sheng Chen, Yun-Jie Song, Chuang Qi, Wang-Long Deng, Zhen-Gang Yuan
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer. Nature communications 14 (1) (2023)
Tian-Mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-Jie Tao, Xi-Yun Chen, Qin Han, Zhuo Cheng, Pei-Pei Shang, Yu-Long Dong, He-Ming Xu, Lie-Ping Guo, Dong-Sheng Chen, Yun-Jie Song, Chuang Qi, Wang-Long Deng, Zhen-Gang Yuan
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer. Nature communications 14 (1) (2023)
Tian-Mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-Jie Tao, Xi-Yun Chen, Qin Han, Zhuo Cheng, Pei-Pei Shang, Yu-Long Dong, He-Ming Xu, Lie-Ping Guo, Dong-Sheng Chen, Yun-Jie Song, Chuang Qi, Wang-Long Deng, Zhen-Gang Yuan
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer. Nature communications 14 (1) (2023)
Tian-Mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-Jie Tao, Xi-Yun Chen, Qin Han, Zhuo Cheng, Pei-Pei Shang, Yu-Long Dong, He-Ming Xu, Lie-Ping Guo, Dong-Sheng Chen, Yun-Jie Song, Chuang Qi, Wang-Long Deng, Zhen-Gang Yuan
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer. Nature communications 14 (1) (2023)

Yun-Jie Song.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yun-Jie Song